325 Capital LLC
In its 13F for Q3 2025 (holdings as of September 30, 2025, filed November 14, 2025), 325 Capital LLC reported 12 stock positions worth $329.1 million. Its top holding was Astronics (ATRO) at 18.9% of the portfolio, followed by American Public Education (APEI, 18.3%) and Blue Bird (BLBD, 13.5%). Compared with Q2 2025, it opened 1 new position and added to 1. The biggest buy was a new position in Magnite (MGNI).
- Most Recent 13F
- Q2 2026
- Location
- NEW YORK, NY
- CIK
- 0001873893
- Portfolio Value
- $329.1M (Q3 2025)
- SEC Filing
- 0001214659-25-016612 ↗ filed Nov 14, 2025
Holdings Value
Holdings 12 stocks · $329.1M
| ATRO Astronics Corp. | 18.86% | 1,360,675 | $62.1M | No change |
| APEI American Public Education | 18.33% | 1,528,503 | $60.3M | No change |
| BLBD Blue Bird Corp. | 13.52% | 773,193 | $44.5M | No change |
| ASTH Astrana Health Inc. | 10.29% | 1,193,953 | $33.8M | Add +34.6% |
| MPAA Motorcar Parts of America Inc. | 10.15% | 2,018,795 | $33.4M | No change |
| SPIR Spire Global Inc. | 6.26% | 1,875,000 | $20.6M | No change |
| AIOT Powerfleet Inc. | 5.81% | 3,646,379 | $19.1M | No change |
| LFCR Lifecore Biomedical Inc. | 4.84% | 2,162,466 | $15.9M | No change |
| MGNI Magnite Inc. | 4.30% | 650,061 | $14.2M | New |
| BTMD Biote Corp. Class A | 4.15% | 4,548,127 | $13.6M | No change |
| MULTISENSOR AI HOLDINGS INC | 1.84% | 9,375,000 | $6.0M | No change |
| TACT Transact Technologies Inc. | 1.67% | 1,011,789 | $5.5M | No change |
Portfolio Sells Q2 2025 → Q3 2025
| None this quarter. | |||
Portfolio Buys Q2 2025 → Q3 2025
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 12 | $419.5M | ASTH, MGNI, APEI, BLBD, SPIR |
| Q1 2026 | 12 | $274.5M | APEI, ASTH, BLBD, MGNI, SPIR |
| Q4 2025 | 13 | $285.4M | APEI, ASTH, MGNI, BLBD, MPAA |
| Q3 2025 | 12 | $329.1M | ATRO, APEI, BLBD, ASTH, MPAA |
| Q2 2025 | 11 | $253.3M | APEI, ATRO, BLBD, MPAA, SPIR |
| Q1 2025 | 11 | $241.4M | APEI, ATRO, ASTH, BLBD, AIOT |
| Q4 2024 | 12 | $258.7M | APEI, BLBD, BTMD, ASTH, ATRO |
| Q3 2024 | 11 | $236.2M | ASTH, BLBD, ATRO, APEI, BTMD |
| Q2 2024 | 13 | $238.1M | BLBD, ATRO, BTMD, ASTH, APEI |
| Q1 2024 | 12 | $216.6M | BLBD, ATRO, SGOV, ASTH, BTMD |